Body

Hydrochlorothiazide Safer than Chlorthalidone for Treating Elderly Patients with Hypertension

Considering the potential for adverse effects, hydrochlorothiazide may be a safer treatment than chlorthalidone for elderly patients with uncomplicated hypertension.

Protein pair promotes skin regeneration

New findings reveal a previously unknown role for DSG1/Erbin in skin disorders. In a companion commentary, John Stanley of the University of Pennsylvania discusses how these findings contribute to our understanding of how skin is maintained.

Because skin protects our bodies from pathogens and harsh environmental conditions, it must undego constant renewal.

Study shows that bedtime regularity predicts CPAP compliance

DARIEN, IL – A new study suggests that regularity of bedtime prior to initiation of continuous positive airway pressure (CPAP) therapy is an important factor that may influence treatment compliance in adults with obstructive sleep apnea (OSA).

Results show that bedtime variability was a significant predictor of CPAP adherence, which was defined as four or more hours of treatment use per night. The odds of one-month CPAP non-adherence were 3.7 times greater for every one unit increase in habitual, or pre-treatment, bedtime variability.

First corneal transplant with pre-loaded donor tissue performed at Mass. Eye and Ear

Boston (May 7, 2013) – The first successful cornea transplant with donor endothelial tissue preloaded by an eye bank has been performed at Massachusetts Eye and Ear in Boston, Mass. Roberto Pineda II, M.D., Director of the Refractive Surgery Service at Mass. Eye and Ear, and an Associate Professor of Ophthalmology at Harvard Medical School, recently performed the groundbreaking transplant.

US urban trees store carbon, provide billions in economic value

WASHINGTON, May 7, 2013 – From New York City's Central Park to Golden Gate Park in San Francisco, America's urban forests store an estimated 708 million tons of carbon, an environmental service with an estimated value of $50 billion, according to a recent U.S. Forest Service study.

Annual net carbon uptake by these trees is estimated at 21 million tons and $1.5 billion in economic benefit.

Amplification of a Stat5 gene produces excess oncogenic protein that drives prostate cancer spread

(PHILADELPHIA) An international group of investigators, led by researchers at Thomas Jefferson University's Kimmel Cancer Center, have solved the mystery of why a substantial percentage of castrate-resistant metastatic prostate cancer cells contain abnormally high levels of the pro-growth protein Stat5. They discovered that the gene that makes the protein is amplified — duplicated many times over — in these cancer cells, which allows them to produce excess amounts of the oncogenic protein.

Genetic variations associated with susceptibility to bacteria linked to stomach disorders

Two genome-wide association studies and a subsequent meta-analysis have found that certain genetic variations are associated with susceptibility to Helicobacter pylori, a bacteria that is a major cause of gastritis and stomach ulcers and is linked to stomach cancer, findings that may help explain some of the observed variation in individual risk for H pylori infection, according to a study in the May 8 issue of JAMA.

Salk scientists find potential therapeutic target for Cushing's disease

LA JOLLA, CA---Scientists at the Salk Institute for Biological Studies have identified a protein that drives the formation of pituitary tumors in Cushing's disease, a development that may give clinicians a therapeutic target to treat this potentially life-threatening disorder.

Duke researchers describe how breast cancer cells acquire drug resistance

DURHAM, N.C. -- A seven-year quest to understand how breast cancer cells resist treatment with the targeted therapy lapatinib has revealed a previously unknown molecular network that regulates cell death. The discovery provides new avenues to overcome drug resistance, according to researchers at Duke Cancer Institute.

Pitt discovery holds potential in destroying drug-resistant bacteria

Through the serendipity of science, researchers at the University of Pittsburgh have discovered a potential treatment for deadly, drug-resistant bacterial infections that uses the same approach that HIV uses to infect cells.

The National Institutes of Health-supported discovery will be described in the June issue of the journal Antimicrobial Agents and Chemotherapy. It is especially promising in the development of a potential treatment for lung infections in people with cystic fibrosis.

Twitter analysis shows Boston bombings had little effect on immigration reform conversations

An analysis by researchers at the Institute for Immigration Research (IIR) at George Mason University shows that the Boston Marathon bombings had little effect on conversations on social media regarding immigration reform.

Using two different data mining applications, the researchers collected more than 750,000 tweets containing the word "immigration" beginning in February 2013.

Initiation of breast cancer treatment varies by race; patient-doctor communication is key

WASHINGTON — Black women with breast cancer were found to be three times more likely than their white counterparts to delay treatment for more than 90 days — a time delay associated with increased deaths from the disease, according to a new study led by researchers at Georgetown Lombardi Comprehensive Cancer Center.

Study: MicroRNA cooperation mutes breast cancer oncogenes

A University of Colorado Cancer Center study recently published in the journal Cell Death & Disease shows that turning up a few microRNAs a little may offer as much anti-breast-cancer activity as turning up one microRNA a lot – and without the unwanted side effects.

New insights into Ebola infection pave the way for much-needed therapies

The Ebola virus is among the deadliest viruses on the planet, killing up to 90% of those infected, and there are no approved vaccines or effective therapies. A study published by Cell Press on May 7th in the Biophysical Journal reveals how the most abundant protein making up the Ebola virus—viral protein 40 (VP40)—allows the virus to leave host cells and spread infection to other cells throughout the human body. The findings could lay the foundation for the development of new drugs and strategies for fighting Ebola infection.

Type 1 diabetes and heart disease linked by inflammatory protein

NEW YORK, NY (May 7, 2013) — Type 1 (insulin-dependent) diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating the production of calprotectin, a protein that sparks an inflammatory process that fuels the buildup of artery-clogging plaque. The findings, made in mice and confirmed with human data, suggest new therapeutic targets for reducing heart disease in people with type 1 diabetes.